These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23220980)

  • 21. Proximal buddy in jail technique: A bail out technique to increase guide support.
    Tu T; Tang J; Fang Z; Hu X; Tang L; Zhao Y; Liu Q; Zhou S
    Cardiol J; 2018; 25(2):159-164. PubMed ID: 29240963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary stent embolism to the right posterior cerebral artery.
    Varol S; Şahin İ; Kum G; Katkat F; Okuyan E
    Turk Kardiyol Dern Ars; 2020 Apr; 48(3):304-308. PubMed ID: 32281954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty.
    Buszman P; Zurakowski A; Kinasz L; Gorycki B; Król M; Lewicki A; Flak Z; Milewski K; Zurek P
    Kardiol Pol; 2005 May; 62(5):451-9; discussion 460-1. PubMed ID: 15928722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
    JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct coronary stent implantation: safety, feasibility, and predictors of success of the strategy of direct coronary stent implantation.
    Laarman G; Muthusamy TS; Swart H; Westendorp I; Kiemeneij F; Slagboom T; van der Wieken R
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):443-8. PubMed ID: 11285596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
    Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
    Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.
    Erglis A; Narbute I; Kumsars I; Jegere S; Mintale I; Zakke I; Strazdins U; Saltups A
    J Am Coll Cardiol; 2007 Aug; 50(6):491-7. PubMed ID: 17678730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.
    Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F
    EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
    Angioi M; Barragan P; Cattan S; Collet F; Dupouy P; Durand P; Fajadet J; Finet G; Gerardin B; Gommeaux A; Karsenty B; Loubeyre C; Meyer P; Morice MC; Moulichon MÉ; Sayah S; Silvestri M; Tabone X; Unterseeh T; Wittenberg O; Lablanche JM
    Arch Cardiovasc Dis; 2012 Feb; 105(2):60-7. PubMed ID: 22424323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease.
    Sheiban I; Gerasimou A; Bollati M; Biondi-Zoccai G; Sciuto F; Omedé P; Sillano D; Trevi GP; Moretti C
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):25-31. PubMed ID: 19089932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.
    Stouffer GA; Hirmerova J; Moll S; Rubery B; Napoli M; Ohman EM; Simpson R
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):364-7. PubMed ID: 14988897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideliner catheter facilitated percutaneous coronary artery intervention of an anteriorly displaced and heavily calcified right coronary artery.
    Graidis C; Dimitriadis D; Karasavvidis V
    J Invasive Cardiol; 2012 Oct; 24(10):E222-4. PubMed ID: 23043048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
    Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
    Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.